How do physicians decide whether to subscribe a new drug/therapy when the expected benefit is unclear and still no HTA-assessment available?
SupportExpert
How do physicians decide whether to subscribe a new drug/therapy when the expected benefit is unclear and still no HTA-assessment available?
Share